Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D003402:Creatine Kinase / Q000032:analysis; D003882:Dermatomyositis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007871:Leg Ulcer / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008111:Liver Function Tests; D008171:Lung Diseases / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009132:Muscles / Q000201:enzymology; D009220:Myositis / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D013280:Stomatitis / Q000139:chemically induced
D003402:Creatine Kinase; D011241:Prednisone; D008727:Methotrexate